| RS1599844887 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1599845689 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1599845714 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1599848690 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1599851667 |
WDR62
|
Health Risk |
Likely pathogenic |
Microcephaly 2, primary |
| RS1599852762 |
WDR62
|
Health Risk |
Likely pathogenic |
— |
| RS1599855670 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1599862139 |
NFIX
|
Health Risk |
Pathogenic |
Marshall-Smith syndrome, Marshall-Smith syndrome |
| RS1599862357 |
NFIX
|
Health Risk |
Pathogenic |
— |
| RS1599862464 |
NFIX
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS1599865356 |
RTTN
|
Health Risk |
Likely pathogenic |
Microcephalic primordial dwarfism due to RTTN deficiency, Microcephalic primordial dwarfism due to RTTN deficiency |
| RS1599869510 |
TBXA2R
|
Health Risk |
Likely pathogenic |
Abnormal platelet aggregation, Abnormal platelet aggregation |
| RS1599873586 |
JAK3
|
Health Risk |
Pathogenic |
NK-cell enteropathy, NK-cell enteropathy |
| RS1599873591 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1599874183 |
INSR
|
Health Risk |
Likely pathogenic |
— |
| RS1599875856 |
TNNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1599876167 |
JAK3
|
Health Risk |
Likely pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1599879104 |
LTBP4
|
Health Risk |
Likely pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS1599879570 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
NLRP12-related disorder, Familial cold autoinflammatory syndrome 2 |
| RS1599881881 |
INSR
|
Health Risk |
Likely pathogenic |
— |
| RS1599889628 |
UBA2
|
Health Risk |
Pathogenic |
UBA2-related disorder, ACCES syndrome |
| RS1599890939 |
CIC
|
Health Risk |
Likely pathogenic |
— |
| RS1599892470 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1599893542 |
TGFB1
|
Health Risk |
Likely pathogenic |
Diaphyseal dysplasia, Diaphyseal dysplasia |
| RS1599896616 |
TNNT1
|
Health Risk |
Pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1599907512 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial restrictive cardiomyopathy, Familial restrictive cardiomyopathy |
| RS1599910596 |
CIC
|
Health Risk |
Likely pathogenic |
— |
| RS1599914720 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1599914867 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1599914870 |
RTN2
|
Health Risk |
Likely pathogenic |
— |
| RS1599915131 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599915235 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599922006 |
COQ8B
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 9 |
| RS1599924500 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599925298 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1599925303 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, STK11-related disorder |
| RS1599925344 |
SLC5A5
|
Health Risk |
Likely pathogenic |
— |
| RS1599925362 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfanoid habitus and intellectual disability, Peutz-Jeghers syndrome |
| RS1599926497 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599926521 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1599927564 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599927573 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599927589 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599927622 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599927645 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599927689 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599927721 |
CIC
|
Health Risk |
Likely pathogenic |
CIC-related disorder, CIC-related disorder |
| RS1599928248 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599928254 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1599928360 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599929258 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599929264 |
STK11
|
Health Risk |
Pathogenic |
— |
| RS1599929335 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599929339 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS1599929369 |
STK11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1599937180 |
INSR
|
Health Risk |
Likely pathogenic |
Hyperinsulinism due to INSR deficiency, Hyperinsulinism due to INSR deficiency |
| RS1599937963 |
FKRP
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2I, Autosomal recessive limb-girdle muscular dystrophy type 2I |
| RS1599938271 |
FKRP
|
Health Risk |
Likely pathogenic |
— |
| RS1599938631 |
PRKCG
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 14, Spinocerebellar ataxia type 14 |
| RS1599939853 |
FKRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1599941421 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599941622 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1599942345 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1599943097 |
PRKCG
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia type 14, Spinocerebellar ataxia type 14 |
| RS1599949380 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1599953368 |
TGM6
|
Health Risk |
Likely pathogenic |
— |
| RS1599959574 |
SLC52A3
|
Health Risk |
Pathogenic |
Progressive bulbar palsy of childhood, Progressive bulbar palsy of childhood |
| RS1599962569 |
BCKDHA
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1599964721 |
OPA3
|
Health Risk |
Conflicting classifications of pathogenicity |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS1599968129 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1599982861 |
ETHE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1599991268 |
CRX
|
Health Risk |
Pathogenic |
Stargardt disease, Leber congenital amaurosis 7 |
| RS1599991538 |
CRX
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 1 |
| RS1599991611 |
CRX
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 1, Leber congenital amaurosis 7 |
| RS1599992622 |
CRX
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1599992745 |
CRX
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 2, Leber congenital amaurosis 7 |
| RS1600004624 |
VPS16
|
Health Risk |
Pathogenic |
Dystonia 30, Dystonia 30 |
| RS1600019095 |
ETHE1
|
Health Risk |
Pathogenic |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS1600021258 |
CEBPA
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS1600021341 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1600022240 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1600023511 |
CEBPA
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS1600023950 |
CEBPA
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS1600068013 |
SMARCA4
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1600069637 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS1600073584 |
U2AF2
|
Health Risk |
Pathogenic |
Developmental delay, dysmorphic facies |
| RS1600081783 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600082188 |
SMARCA4
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS1600082359 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600088360 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1600096061 |
PEPD
|
Health Risk |
Likely pathogenic |
— |
| RS1600114562 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1600120873 |
FTL
|
Health Risk |
Pathogenic |
Hereditary hyperferritinemia with congenital cataracts, Neuroferritinopathy |
| RS1600127096 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1600130724 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1600133088 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1600139005 |
CACNA1A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 42 |
| RS1600139781 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1600147235 |
PEPD
|
Health Risk |
Pathogenic |
Prolidase deficiency, Prolidase deficiency |
| RS1600152215 |
CACNA1A
|
Health Risk |
Pathogenic |
— |